122 related articles for article (PubMed ID: 37591850)
1. TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling.
Xia K; Zheng D; Wei Z; Liu W; Guo W
Cell Death Dis; 2023 Aug; 14(8):529. PubMed ID: 37591850
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
Xie X; Li H; Pan J; Han X
Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
[TBL] [Abstract][Full Text] [Related]
3. ZNF692 promotes osteosarcoma cell proliferation, migration, and invasion through TNK2-mediated activation of the MEK/ERK pathway.
Zheng D; Wei Z; Zhang C; Liu W; Gong C; Wu F; Guo W
Biol Direct; 2024 Apr; 19(1):28. PubMed ID: 38650011
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of tripartite motif containing 26 inhibits non-small cell lung cancer cell growth by suppressing PI3K/AKT signaling.
Tao JL; Luo M; Sun H; Zhao HM; Sun QS; Huang ZM
Kaohsiung J Med Sci; 2020 Jun; 36(6):417-422. PubMed ID: 32052576
[TBL] [Abstract][Full Text] [Related]
5. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
6. TRIM26 promotes non-small cell lung cancer survival by inducing PBX1 degradation.
Sun Y; Lin P; Zhou X; Ren Y; He Y; Liang J; Zhu Z; Xu X; Mao X
Int J Biol Sci; 2023; 19(9):2803-2816. PubMed ID: 37324936
[TBL] [Abstract][Full Text] [Related]
7. Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma.
Lu T; Wu Y
Horm Metab Res; 2022 Dec; 54(12):859-865. PubMed ID: 36108622
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of TRIM26 suppresses the proliferation, metastasis, and glycolysis in papillary thyroid carcinoma cells.
Wang K; Chai L; Qiu Z; Zhang Y; Gao H; Zhang X
J Cell Physiol; 2019 Aug; 234(10):19019-19027. PubMed ID: 30927273
[TBL] [Abstract][Full Text] [Related]
9. Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.
Hou CH; Lin FL; Hou SM; Liu JF
Mol Cancer; 2014 Oct; 13():236. PubMed ID: 25326651
[TBL] [Abstract][Full Text] [Related]
10. The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.
Liao S; Xiao S; Chen H; Zhang M; Chen Z; Long Y; Gao L; He J; Ge Y; Yi W; Wu M; Li G; Zhou Y
Int J Oncol; 2017 Nov; 51(5):1497-1507. PubMed ID: 29048616
[TBL] [Abstract][Full Text] [Related]
11. The TRIM-FLMN protein TRIM45 directly interacts with RACK1 and negatively regulates PKC-mediated signaling pathway.
Sato T; Takahashi H; Hatakeyama S; Iguchi A; Ariga T
Oncogene; 2015 Mar; 34(10):1280-91. PubMed ID: 24681954
[TBL] [Abstract][Full Text] [Related]
12. RACK1 degrades MAVS to promote bovine ephemeral fever virus replication via upregulating E3 ubiquitin ligase STUB1.
Zhang Y; Hou P; He DC; Wang H; He H
Vet Microbiol; 2021 Jun; 257():109096. PubMed ID: 33940459
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
14. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
Hermanto U; Zong CS; Li W; Wang LH
Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
[TBL] [Abstract][Full Text] [Related]
15. TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein.
Nakaya Y; Nishizawa T; Nishitsuji H; Morita H; Yamagata T; Onomura D; Murata K
Sci Rep; 2023 Aug; 13(1):13584. PubMed ID: 37604854
[TBL] [Abstract][Full Text] [Related]
16. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
17. TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients.
Luo M; Hou J; Mai H; Chen J; Chen H; Zhou B; Hou J; Jiang DK
Aliment Pharmacol Ther; 2022 Sep; 56(5):878-889. PubMed ID: 35872575
[TBL] [Abstract][Full Text] [Related]
18. Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling.
Xu L; Li J; Tursun M; Hai Y; Tursun H; Mamtimin B; Hasim A
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35616137
[TBL] [Abstract][Full Text] [Related]
19. CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway.
Wang A; Yang W; Li Y; Zhang Y; Zhou J; Zhang R; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2022 Jan; 20(1):16. PubMed ID: 35101055
[TBL] [Abstract][Full Text] [Related]
20. RACK1 promotes the invasive activities and lymph node metastasis of cervical cancer via galectin-1.
Wu H; Song S; Yan A; Guo X; Chang L; Xu L; Hu L; Kuang M; Liu B; He D; Zhao R; Wang L; Wu X; Gu J; Ruan Y
Cancer Lett; 2020 Jan; 469():287-300. PubMed ID: 31705928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
